223 related articles for article (PubMed ID: 27096781)
1. Rush sublingual immunotherapy in canine atopic dermatitis: a prospective pilot study.
Fujimura M; Ishimaru H
Pol J Vet Sci; 2016; 19(1):3-6. PubMed ID: 27096781
[TBL] [Abstract][Full Text] [Related]
2. Clinical and immunological responses of dust mite sensitive, atopic dogs to treatment with sublingual immunotherapy (SLIT).
DeBoer DJ; Verbrugge M; Morris M
Vet Dermatol; 2016 Apr; 27(2):82-7e23. PubMed ID: 26749020
[TBL] [Abstract][Full Text] [Related]
3. A double blind, randomized, placebo controlled trial of the efficacy, quality of life and safety of food allergen-specific sublingual immunotherapy in client owned dogs with adverse food reactions: a small pilot study.
Maina E; Cox E
Vet Dermatol; 2016 Oct; 27(5):361-e91. PubMed ID: 27426929
[TBL] [Abstract][Full Text] [Related]
4. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of subcutaneous, intralymphatic and sublingual immunotherapy for the long-term control of dogs with nonseasonal atopic dermatitis.
Fischer NM; Rostaher A; Favrot C
Vet Dermatol; 2020 Oct; 31(5):365-e96. PubMed ID: 32537789
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of rush immunotherapy with alum-precipitated allergens in canine atopic dermatitis.
Hobi S; Mueller RS
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(3):167-73. PubMed ID: 24920143
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporin A Treatment in Intrinsic Canine Atopic Dermatitis (Atopic-like Dermatitis): Open Trial Study.
Fujimura M; Nakatsuji Y; Ishimaru H
Pol J Vet Sci; 2016 Sep; 19(3):567-572. PubMed ID: 27760033
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
[TBL] [Abstract][Full Text] [Related]
9. Tolerability and clinical efficacy of oral immunotherapy with house dust mites in a model of canine atopic dermatitis: a pilot study.
Marsella R
Vet Dermatol; 2010 Dec; 21(6):566-71. PubMed ID: 20492623
[TBL] [Abstract][Full Text] [Related]
10. Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.
Nuttall TJ; McEwan NA; Bensignor E; Cornegliani L; Löwenstein C; Rème CA
Vet Dermatol; 2012 Feb; 23(1):4-10, e1-2. PubMed ID: 21718368
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.
Nuttall T; Mueller R; Bensignor E; Verde M; Noli C; Schmidt V; Rème C
Vet Dermatol; 2009 Jun; 20(3):191-8. PubMed ID: 19374721
[TBL] [Abstract][Full Text] [Related]
12. Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega.
Litzlbauer P; Weber K; Mueller RS
Cytokine; 2014 Mar; 66(1):54-9. PubMed ID: 24548425
[TBL] [Abstract][Full Text] [Related]
13. Management of canine atopic dermatitis using the plant extract PYM00217: a randomized, double-blind, placebo-controlled clinical study.
Ferguson EA; Littlewood JD; Carlotti DN; Grover R; Nuttall T
Vet Dermatol; 2006 Aug; 17(4):236-43. PubMed ID: 16827666
[TBL] [Abstract][Full Text] [Related]
14. [Intralymphatic immunotherapy: An effective and safe alternative route for canine atopic dermatitis].
Fischer N; Rostaher A; Favrot C
Schweiz Arch Tierheilkd; 2016 Sep; 158(9):646-652. PubMed ID: 27655164
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the effect of pullulan-conjugated Der f 2 allergen-specific immunotherapy on canine atopic dermatitis.
Kawano K; Mizuno T
Vet Dermatol; 2017 Dec; 28(6):583-e141. PubMed ID: 28776792
[TBL] [Abstract][Full Text] [Related]
16. Dermatophagoides farinae-specific immunotherapy in atopic dogs with hypersensitivity to multiple allergens: a randomised, double blind, placebo-controlled study.
Willemse T; Bardagi M; Carlotti DN; Ferrer L; Fondati A; Fontaine J; Leistra M; Noli C; Ordeix L; Scarampella F; Schleifer S; Sinke J; Roosje P
Vet J; 2009 Jun; 180(3):337-42. PubMed ID: 18653361
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the safety of an abbreviated course of injections of allergen extracts (rush immunotherapy) for the treatment of dogs with atopic dermatitis.
Mueller RS; Bettenay SV
Am J Vet Res; 2001 Mar; 62(3):307-10. PubMed ID: 11277192
[TBL] [Abstract][Full Text] [Related]
19. Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial.
Cadot P; Hensel P; Bensignor E; Hadjaje C; Marignac G; Beco L; Fontaine J; Jamet JF; Georgescu G; Campbell K; Cannon A; Osborn SC; Messinger L; Gogny-Goubert M; Dubreuil P; Moussy A; Hermine O
Vet Dermatol; 2011 Dec; 22(6):554-64. PubMed ID: 21668810
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of immunotherapy in dogs with atopic dermatitis using a mannan-Dermatophagoides farinae allergoid targeting dendritic cells.
González JL; Zalve V; Fernández-Caldas E; Cases B; Subiza JL; Casanovas M
Vet Dermatol; 2018 Oct; 29(5):449-e152. PubMed ID: 30183126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
